Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Neoplasms 3Hemangioma, Capillary 2Anxiety Disorders 2Weight Loss 1Vomiting 1Urinary Incontinence, Stress 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Shoulder Pain 1Respiratory Aspiration 1Psychomotor Agitation 1Prostatic Neoplasms 1Premature Birth 1Polycystic Ovary Syndrome 1Pediatric Obesity 1Pancreatic Neoplasms 1Pain, Postoperative 1Ovarian Cysts 1Obesity 1Neuromuscular Diseases 1Neuroblastoma 1Nasopharyngeal Carcinoma 1Myofibroma 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Multiple Myeloma 1Menstruation Disturbances 1Lymphoma, Follicular 1Lung Neoplasms 1

Interventions

Fulvestrant 6olaparib 4Letrozole 4trastuzumab deruxtecan 3Aromatase Inhibitors 3Anastrozole 3sacituzumab govitecan 2pyrotinib 2eribulin 2dalpiciclib 2Paclitaxel 2Goserelin 2Gonadotropin-Releasing Hormone 2FCN-437c 2Capecitabine 2toripalimab 1talazoparib 1sonidegib 1ribociclib 1pembrolizumab 1neratinib 1liposomal doxorubicin 1elacestrant 1disitamab vedotin 1ceralasertib 1capivasertib 1balixafortide 1apatinib 1abemaciclib 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Breast Cancer × Population Groups × Clear all
NCT06290466 2024-03-04

Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Ahon Pharmaceutical Co., Ltd.

Phase 1 Completed
18 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡